Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3072)
All Articles published online
|
Jun 14, 2008 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Delis SG, Dervenis C. Selection criteria for liver resection in patients with hepatocellular carcinoma and chronic liver disease. World J Gastroenterol 2008; 14(22): 3452-3460 [PMID: 18567070 DOI: 10.3748/wjg.14.3452] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i22/3452.htm |
| Number | Citing Articles |
| 1 |
Jongmoo Park, Jae Won Park, Min Kyu Kang. Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma. Yeungnam University Journal of Medicine 2019; 36(3): 192 doi: 10.12701/yujm.2019.00269
|
| 2 |
Christine E. Orr, Peter L. Wang, Lina Chen, Tao Wang, Ezio Laconi. Features of fibrosis regression abound in “non-cirrhotic” patients with resected hepatocellular carcinoma. PLOS ONE 2022; 17(5): e0267474 doi: 10.1371/journal.pone.0267474
|
| 3 |
Ramy Abdlaty, Mohamed A. Abbass, Ahmed M. Awadallah. Radiofrequency ablation for liver: Comparison between expert eye and hyperspectral imaging assessment. Photodiagnosis and Photodynamic Therapy 2022; 37: 102699 doi: 10.1016/j.pdpdt.2021.102699
|
| 4 |
Louise J. Murray, Laura A. Dawson. Advances in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma. Seminars in Radiation Oncology 2017; 27(3): 247 doi: 10.1016/j.semradonc.2017.02.002
|
| 5 |
Belal Abousaida, Cheng-en Hsieh, Bhanu P. Venkatesulu, Sunil Krishnan. Radiotherapy of Liver Cancer. 2021; : 73 doi: 10.1007/978-981-16-1815-4_6
|
| 6 |
Philip Coffin, Aiwu He. Hepatocellular Carcinoma: Past and Present Challenges and Progress in Molecular Classification and Precision Oncology. International Journal of Molecular Sciences 2023; 24(17): 13274 doi: 10.3390/ijms241713274
|
| 7 |
Liang-Cheng Chen, Hon-Yi Lin, Shih-Kai Hung, Wen-Yen Chiou, Moon-Sing Lee. Role of modern radiotherapy in managing patients with hepatocellular carcinoma. World Journal of Gastroenterology 2021; 27(20): 2434-2457 doi: 10.3748/wjg.v27.i20.2434
|
| 8 |
Takashi Tanaka, Kazuhide Takata, Takashi Miyayama, Kumiko Shibata, Hiromi Fukuda, Ryo Yamauchi, Atsushi Fukunaga, Keiji Yokoyama, Satoshi Shakado, Shotaro Sakisaka, Fumihito Hirai. Long-term outcome and eligibility of radiofrequency ablation for hepatocellular carcinoma over 3.0 cm in diameter. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-43516-w
|
| 9 |
Qiangqiang Zhong, Baokang Zhao, Xiao She, Xiangjie Liu, Xiaosheng Tan. HMGA2 as a prognostic and immune biomarker in hepatocellular carcinoma: Comprehensive analysis of the HMG family and experiments validation. PLOS ONE 2024; 19(11): e0311204 doi: 10.1371/journal.pone.0311204
|
| 10 |
Joanna K. Duncan, Ning Ma, Thomas D. Vreugdenburg, Alun L. Cameron, Guy Maddern. Gadoxetic acid-enhanced MRI for the characterization of hepatocellular carcinoma: A systematic review and meta-analysis. Journal of Magnetic Resonance Imaging 2017; 45(1): 281 doi: 10.1002/jmri.25345
|
| 11 |
Amit G. Singal, Kirhan Özgürdal, Xiaozhou Fan, Zdravko Vassilev, Xiaoyun Pan, Jasjit K. Multani, Chi-Chang Chen, Zifan Zhou, Jing He, Federica Pisa. Real-World Systemic Treatment Patterns after Atezolizumab and Bevacizumab in Patients with Hepatocellular Carcinoma in the United States. Cancers 2023; 15(23): 5532 doi: 10.3390/cancers15235532
|
| 12 |
Diwakar Suresh, Akshatha N. Srinivas, Akila Prashant, Kuzhuvelil B. Harikumar, Divya P. Kumar. Therapeutic options in hepatocellular carcinoma: a comprehensive review. Clinical and Experimental Medicine 2023; 23(6): 1901 doi: 10.1007/s10238-023-01014-3
|
| 13 |
Marcelo Guimaraes, Renan Uflacker. Locoregional Therapy for Hepatocellular Carcinoma. Clinics in Liver Disease 2011; 15(2): 395 doi: 10.1016/j.cld.2011.03.013
|
| 14 |
Jennifer Uyei, Tamar H. Taddei, David E. Kaplan, Michael Chapko, Elizabeth R. Stevens, R. Scott Braithwaite, Curtis J. Wray. Setting ambitious targets for surveillance and treatment rates among patients with hepatitis C related cirrhosis impacts the cost-effectiveness of hepatocellular cancer surveillance and substantially increases life expectancy: A modeling study. PLOS ONE 2019; 14(8): e0221614 doi: 10.1371/journal.pone.0221614
|
| 15 |
Anna Podlasek, Maheeba Abdulla, Dieter Broering, Khalid Bzeizi. Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma. Cancers 2023; 15(13): 3347 doi: 10.3390/cancers15133347
|
| 16 |
Camille Hardy-Abeloos, Stanislav Lazarev, Meng Ru, Edward Kim, Aaron Fischman, Erin Moshier, Kenneth Rosenzweig, Michael Buckstein. Safety and Efficacy of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma After Segmental Transarterial Radioembolization. International Journal of Radiation Oncology*Biology*Physics 2019; 105(5): 968 doi: 10.1016/j.ijrobp.2019.09.006
|
| 17 |
Young Chul Kim, Myeong‐Jin Kim, Young Nyun Park, Kyung Sik Kim, Sang Hoon Ahn, Seung Eun Jung, Jai Keun Kim. Relationship between severity of liver dysfunction and the relative ratio of liver to aortic enhancement (RE) on MRI using hepatocyte‐specific contrast. Journal of Magnetic Resonance Imaging 2014; 39(1): 24 doi: 10.1002/jmri.24100
|
| 18 |
Parag Roy, K.M. Parthasarathy. Prolonged response to Tyrosine Kinase Inhibitors followed by Immunotherapy in metastatic hepatocellular carcinoma: A rare case report. Journal of Cancer Research and Therapeutics 2023; 19(5): 1457 doi: 10.4103/jcrt.JCRT_1251_21
|
| 19 |
Kate Hallsworth, Misti V McCain, Roisin Fallen-Bailey, Morven C Brown, Samuel T Orange, Helen L Reeves. Is home-based, virtually delivered, group exercise feasible and acceptable for older patients with hepatocellular carcinoma? A non-randomised feasibility study (TELEX-Liver Cancer). BMJ Open 2024; 14(6): e082155 doi: 10.1136/bmjopen-2023-082155
|
| 20 |
Ramy Abdlaty, Mohamed A. Abbass, Ahmed M. Awadallah. High Precision Monitoring of Radiofrequency Ablation for Liver Using Hyperspectral Imaging. Annals of Biomedical Engineering 2021; 49(9): 2430 doi: 10.1007/s10439-021-02797-w
|
| 21 |
Michael I. Miga, Edward L. Brewer, Logan W. Clements, Jarrod A. Collins, Derek J. Doss, Jon S. Heiselman, Chris D. Pavas, Edward H. Wisdom, Baowei Fei, Cristian A. Linte. The image-to-physical liver registration sparse data challenge. Medical Imaging 2019: Image-Guided Procedures, Robotic Interventions, and Modeling 2019; : 50 doi: 10.1117/12.2513952
|
| 22 |
Michael Karin. New insights into the pathogenesis and treatment of non-viral hepatocellular carcinoma: a balancing act between immunosuppression and immunosurveillance. Precision Clinical Medicine 2018; 1(1): 21 doi: 10.1093/pcmedi/pby005
|
| 23 |
Mutlay Sayan, Nikhil Yegya-Raman, Stephanie H. Greco, Bin Gui, Andrew Zhang, Anupama Chundury, Miral S. Grandhi, Howard S. Hochster, Timothy J. Kennedy, Russell C. Langan, Usha Malhotra, Vinod K. Rustgi, Mihir M. Shah, Kristen R. Spencer, Darren R. Carpizo, John L. Nosher, Salma K. Jabbour. Rethinking the Role of Radiation Therapy in the Treatment of Unresectable Hepatocellular Carcinoma: A Data Driven Treatment Algorithm for Optimizing Outcomes. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00345
|
| 24 |
David Chadow, Paul Haser, Alok Aggarwal, Roberto Perezgrovas-Olaria, Giovanni Soletti, Christopher Lau, Ricardo Castillo, Vijay Jaswani, Mario Gaudino, Hal Chadow. Aspiration thrombectomy for inferior vena cava tumor thrombus arising from hepatocellular carcinoma. Journal of Vascular Surgery Cases, Innovations and Techniques 2022; 8(3): 538 doi: 10.1016/j.jvscit.2022.06.024
|
| 25 |
Sabine Gerum, Christian Heinz, Claus Belka, Franziska Walter, Philipp Marius Paprottka, Enrico N De Toni, Falk Roeder. Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a multimodal treatment setting. Strahlentherapie und Onkologie 2020; 196(4): 334 doi: 10.1007/s00066-019-01540-8
|
| 26 |
Chai Hong Rim, Hyun Ju Kim, Jinsil Seong. Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies. Radiotherapy and Oncology 2019; 131: 135 doi: 10.1016/j.radonc.2018.12.005
|
| 27 |
Belal Abousaida, Danushka Seneviratne, Bradford S Hoppe, Stephen J Ko, Aroumougame Asaithamby, Francis A Cucinotta, Jessica M Kirwan, Kabir Mody, Beau Toskich, Jonathan B Ashman, Christopher L Hallemeier, Sunil Krishnan. Carbon Ion Radiotherapy in the Management of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2021; : 1169 doi: 10.2147/JHC.S292516
|
| 28 |
Ashraf S. Hasanin, Fatma M.A. Mahmoud, Hossam M. Soliman. Factors affecting acid base status during hepatectomy in cirrhotic patients. Egyptian Journal of Anaesthesia 2013; 29(4): 305 doi: 10.1016/j.egja.2013.05.003
|
| 29 |
Takahisa Eriguchi, Nobuhiro Tsukamoto, Nobuko Kuroiwa, Takafumi Nemoto, Takeru Ogata, Yusuke Okubo, Shigeru Nakano, Akitomo Sugawara. Repeated Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma. Practical Radiation Oncology 2021; 11(1): 44 doi: 10.1016/j.prro.2020.08.002
|
| 30 |
Vijay Harish Somasundaram, Rashmi Pillai, Giridharan Malarvizhi, Anusha Ashokan, Siddaramana Gowd, Reshmi Peethambaran, Shanmugasundaram Palaniswamy, AKK Unni, Shantikumar Nair, Manzoor Koyakutty. Biodegradable Radiofrequency Responsive Nanoparticles for Augmented Thermal Ablation Combined with Triggered Drug Release in Liver Tumors. ACS Biomaterials Science & Engineering 2016; 2(5): 768 doi: 10.1021/acsbiomaterials.5b00511
|
| 31 |
Sakue Masuda, Toshitaka Tsukiyama, Yumiko Minagawa, Kazuya Koizumi, Makoto Kako, Takeshi Kinbara, Uojima Haruki. Hepatocellular carcinoma effective stereotactic body radiotherapy using Gold Anchor and the Synchrony system: Two case reports and review of literature. World Journal of Clinical Cases 2022; 10(8): 2591-2603 doi: 10.12998/wjcc.v10.i8.2591
|
| 32 |
Sung Hoon Chang, Tae Suk Kim, Yong Hwan Jeon, Nuri Hyun Jung, Dae Hee Choi. Novel management of expected post-radiotherapy complications in hepatocellular carcinoma patients: a case report. Journal of Liver Cancer 2022; 22(2): 183 doi: 10.17998/jlc.2022.08.03
|
| 33 |
Christian N. Schill, William H. Smith. Liver Cancer - Multidisciplinary Approach. 2024; doi: 10.5772/intechopen.1005029
|
| 34 |
Anh Le Tuan Nguyen, Christopher Leigh Blizzard, Kwang Chien Yee, Andrew John Palmer, Barbara de Graaff. Survival of primary liver cancer for people from culturally and linguistically diverse backgrounds in Australia. Cancer Epidemiology 2022; 81: 102252 doi: 10.1016/j.canep.2022.102252
|
| 35 |
Hendrik Rathke, Bernd Hamm, Felix Guettler, Philipp Lohneis, Andrea Stroux, Britta Suttmeyer, Martin Jonczyk, Ulf Teichgräber, Maximilian de Bucourt. Volume comparison of radiofrequency ablation at 3- and 5-cm target volumes for four different radiofrequency generators: MR volumetry in an open 1-T MRI system versus macroscopic measurement. Biomedical Engineering / Biomedizinische Technik 2015; 60(6) doi: 10.1515/bmt-2014-0174
|
| 36 |
Brett H. Diamond, Kara Banson, Jonathan Ayash, Peter Lee, Utkarsh C. Shukla, Gavin Jones, Paul Rava, Thomas J. Fitzgerald, Shirin Sioshansi. Outcomes After Stereotactic Body Radiation for Hepatocellular Carcinoma in Patients With Child-Pugh A Versus Child-Pugh B/C Cirrhosis. Advances in Radiation Oncology 2024; 9(12): 101631 doi: 10.1016/j.adro.2024.101631
|
| 37 |
Nandlal Yadawa, Uday P. Shahi, Abhijit Mandal, Ashish Verma, Kiran Kumari, Lalit M. Aggrawal, Isha Jaiswal, Ankur Mourya, Anil K. Jaiswal, Pammy Srivastava. Percutaneous high-dose-rate interstitial brachytherapy for non-resectable, chemo resistant malignant lesion of lung and liver. Journal of Cancer Research and Therapeutics 2023; 19(Suppl 2): S807 doi: 10.4103/jcrt.jcrt_1351_22
|
| 38 |
Sandra Strainiene, Kotryna Sedleckaite, Juozas Jarasunas, Ilona Savlan, Juozas Stanaitis, Ieva Stundiene, Tomas Strainys, Valentina Liakina, Jonas Valantinas. Complicated course of biliary inflammatory myofibroblastic tumor mimicking hilar cholangiocarcinoma: A case report and literature review. World Journal of Clinical Cases 2021; 9(21): 6155-6169 doi: 10.12998/wjcc.v9.i21.6155
|
| 39 |
Liang-Cheng Chen, Hon-Yi Lin, Moon-Sing Lee, Wen-Yen Chiou, Li-Wen Huang, Chia-Hui Chew, Feng-Chun Hsu, Shih-Kai Hung. Effectiveness of individual audio-visual coaching, respiratory modulated stereotactic body radiotherapy for localized hepatocellular carcinoma. Tzu Chi Medical Journal 2021; 33(4): 380 doi: 10.4103/tcmj.tcmj_247_20
|
| 40 |
Bardia Bidarmaghz, Marwan Idrees, Yoo Young Lee, Peter Hodgkinson. Large hepatocellular carcinoma treated with sequential SBRT and immunotherapy with anti-VEGF (Vascular Endothelial Growth Factor) therapy. BMJ Case Reports 2023; 16(12): e256931 doi: 10.1136/bcr-2023-256931
|
| 41 |
Sabine Gerum, Alexandra D Jensen, Falk Roeder. Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-review. World Journal of Gastrointestinal Oncology 2019; 11(5): 367-376 doi: 10.4251/wjgo.v11.i5.367
|
| 42 |
Piyush Goyal, Riad Salem, Samdeep K. Mouli. Role of interventional oncology in hepatocellular carcinoma: Future best practice beyond current guidelines. The British Journal of Radiology 2022; 95(1138) doi: 10.1259/bjr.20220379
|
| 43 |
Jin-Xiu Liu, Xiaoping Zhang, Wen-Hua Xu, Xiao-Dan Hao. The role of RNA modifications in hepatocellular carcinoma: functional mechanism and potential applications. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1439485
|
| 44 |
Anna G. Sorace, Asser A. Elkassem, Samuel J. Galgano, Suzanne E. Lapi, Benjamin M. Larimer, Savannah C. Partridge, C. Chad Quarles, Kirsten Reeves, Tiara S. Napier, Patrick N. Song, Thomas E. Yankeelov, Stefanie Woodard, Andrew D. Smith. Imaging for Response Assessment in Cancer Clinical Trials. Seminars in Nuclear Medicine 2020; 50(6): 488 doi: 10.1053/j.semnuclmed.2020.05.001
|
| 45 |
Andrew Kennedy, Douglas Coldwell, Bruno Sangro, Harpreet Wasan, Riad Salem. Integrating Radioembolization (90Y Microspheres) Into Current Treatment Options for Liver Tumors. American Journal of Clinical Oncology 2012; 35(1): 81 doi: 10.1097/COC.0b013e3181ec60b8
|
| 46 |
Mohamed A. Abbass, Syed A. Ahmad, Neeraja Mahalingam, K. Sameer Krothapalli, Jack A. Masterson, Marepalli B. Rao, Peter G. Barthe, T. Douglas Mast, Gayle E. Woloschak. In vivo ultrasound thermal ablation control using echo decorrelation imaging in rabbit liver and VX2 tumor. PLOS ONE 2019; 14(12): e0226001 doi: 10.1371/journal.pone.0226001
|
| 47 |
Yanyan Long, Yan Liang, Shujie Li, Jing Guo, Ying Wang, Yan Luo, Yongzhong Wu. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies. Radiation Oncology 2021; 16(1) doi: 10.1186/s13014-021-01761-1
|